Marex Group »

Eyepoint Pharmaceuticals shares owned by Marex Group

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Marex Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $873k 48k 18.27

More positions owned by Marex Group

Meta Platforms Cl A (META)
Tesla Motors (TSLA)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Booking Holdings (BKNG)
Apple (AAPL)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Microsoft Corporation (MSFT)
Strategy Cl A New (MSTR)
Valkyrie Bitcoin (BRRR)
Home Depot (HD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Netflix (NFLX)

View all positions for Marex Group

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
BlackRock
Federated Investors
Adage Capital Partners GP
Franklin Resources
Vanguard Group
Paradigm Biocapital Advisors
TCG Crossover Management
OrbiMed Advisors
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals